Log In
Print
BCIQ
Print
Print this Print this
 

Anti-CD38

  Manage Alerts
Collapse Summary General Information
Company Amorfix Life Sciences Ltd.
DescriptionMAb against CD38 disease specific epitopes (DSEs)
Molecular Target CD38
Mechanism of Action 
Latest Stage of DevelopmentDiscovery
IndicationCancer
Partner

Apexigen Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today